Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBDV for HIV-associated neuropathic pain
2014-005344-17Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neuralgia and HIV-associated neuropathy comparing Cannabidivarin with Placebo (2 arms). Primary endpoint: Pain intensity responder rate. Started Jan 2015; status: completed.
02
Drugs
cannabidivarin
03
Conditions
NeuralgiaHIV-associated neuropathy
Beyond the preview
Go deeper on 2014-005344-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005344-17.